share_log

華領醫藥-B：股份發行人的證券變動月報表

HUA MEDICINE-B: Monthly Return of Equity Issuer on Movements in Securities

HKEX ·  Nov 5, 2024 16:41

Summary by Moomoo AI

華領醫藥於2024年11月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年10月31日的公司股份變動情況。報告顯示，華領醫藥的法定/註冊股本及已發行股份數量在本月內未有變動，普通股的法定/註冊股本總額及已發行股份總數均維持在2,000,000,000股，每股面值0.001美元，總額2,000,000美元。此外，公司的股份期權計劃中，本月內股份期權數目有所減少，由上月底的52,799,265股減至52,357,591股，主要是因為441,674股股份期權已失效。公司確認，所有證券發行或庫存股份的出售或轉讓均已獲得董事會正式授權，並遵守所有相關上市規則及法律規定。
華領醫藥於2024年11月5日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年10月31日的公司股份變動情況。報告顯示，華領醫藥的法定/註冊股本及已發行股份數量在本月內未有變動，普通股的法定/註冊股本總額及已發行股份總數均維持在2,000,000,000股，每股面值0.001美元，總額2,000,000美元。此外，公司的股份期權計劃中，本月內股份期權數目有所減少，由上月底的52,799,265股減至52,357,591股，主要是因為441,674股股份期權已失效。公司確認，所有證券發行或庫存股份的出售或轉讓均已獲得董事會正式授權，並遵守所有相關上市規則及法律規定。
Hua Ling Pharmaceuticals submitted the latest Securities Change Monthly Report to the Hong Kong Exchanges and Clearing Limited on November 5, 2024, reporting the company's shareholding changes up to October 31, 2024. The report shows that there have been no changes in the statutory/registered share capital and the number of shares issued by Hua Ling Pharmaceuticals within this month, with the total amount of statutory/registered share capital and the total number of issued shares of common stock remaining at 2,000,000,000 shares, with a face value of $0.001 per share, totaling $2,000,000. Additionally, within the company's share options plan, the number of share options has decreased this month from 52,799,265 shares at the end of last month to 52,357,591 shares, mainly due to 441,674 share options being expired. The company confirms that all issuance of securities or sale/transfers of treasury shares have obtained formal approval from the Board of Directors and comply with all relevant listing rules and legal requirements.
Hua Ling Pharmaceuticals submitted the latest Securities Change Monthly Report to the Hong Kong Exchanges and Clearing Limited on November 5, 2024, reporting the company's shareholding changes up to October 31, 2024. The report shows that there have been no changes in the statutory/registered share capital and the number of shares issued by Hua Ling Pharmaceuticals within this month, with the total amount of statutory/registered share capital and the total number of issued shares of common stock remaining at 2,000,000,000 shares, with a face value of $0.001 per share, totaling $2,000,000. Additionally, within the company's share options plan, the number of share options has decreased this month from 52,799,265 shares at the end of last month to 52,357,591 shares, mainly due to 441,674 share options being expired. The company confirms that all issuance of securities or sale/transfers of treasury shares have obtained formal approval from the Board of Directors and comply with all relevant listing rules and legal requirements.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated